Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026)
Viking Therapeutics (VKTX) reported Exchange Rate Effect of $16000.0 for Q1 2026, up 1500.0% on a YoY basis from $1000.0 in Q1 2025, and up 77.78% sequentially from $9000.0 in Q4 2025.
Viking Therapeutics (VKTX) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Viking Therapeutics (VKTX) has 5 years of Exchange Rate Effect data on file, last reported at $16000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 1500.0% year-over-year to $16000.0; the trailing twelve-month figure through Mar 2026 stood at $7000.0 (up 107.07% YoY), and the FY2025 full-year result was -$8000.0, up 94.59% from the prior year.
- Exchange Rate Effect improved to $16000.0 in Q1 2026, from $9000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $141000.0 in Q4 2022 to a low of -$223000.0 in Q3 2022.
- A 5-year average of -$16800.0 and a median of -$6000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect tumbled 500.0% in 2025 and jumped 1500.0% in 2026, its largest moves.
- Tracing VKTX's Exchange Rate Effect over 5 years: stood at $141000.0 in 2022, then slumped by 64.54% to $50000.0 in 2023, then slumped by 248.0% to -$74000.0 in 2024, then jumped by 112.16% to $9000.0 in 2025, then jumped by 77.78% to $16000.0 in 2026.
- Business Quant data shows VKTX's Exchange Rate Effect at $16000.0 in Q1 2026, $9000.0 in Q4 2025, and -$6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viking Therapeutics | 4.09 Bn | 4.09 Bn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Sep 30, 2024 | -29,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Mar 31, 2024 | -48,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |